Myriad Genetics | MYGN - Ebitda

Stock Price
4.41
Daily Change
0.03 0.68%
Monthly
-24.10%
Yearly
-62.44%
Q1 Forecast
4.16

Myriad Genetics reported $10.3M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 466M 5M Jun/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Danaher USD 2.13B 252M Dec/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Illumina USD 332M 12M Sep/2025
J&J USD 9.52B 389M Sep/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
OraSure Technologies USD 920K 9.87M Jun/2024
Pacific Biosciences Of California USD -73.24M 3.12M Sep/2023
Quest Diagnostics USD 537M 24M Dec/2025
Quidel USD 153.3M 23.8M Dec/2025
Repligen USD 39.54M 3.61M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Standard Biotools USD -16.54M 2.26M Sep/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Veracyte USD 39.73M 3.96M Sep/2025
Waters USD 380.97M 85.83M Dec/2025